PositiveID Chairman and CEO William J. Caragol, called into to update listeners on the latest news for the company. PositiveID Corporation (OTCBB: PSID) develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFS, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit